img

Global Typhoid Fever Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Typhoid Fever Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.
The global Typhoid Fever Vaccines market size was US$ 211.4 million in 2022 and is forecast to a readjusted size of US$ 344 million by 2034 with a CAGR of 6.7% during the forecast period 2024-2034.
The United States market for Typhoid Fever Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Typhoid Fever Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Typhoid Fever Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Typhoid Fever Vaccines include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium and China National Biotec Group, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Typhoid Fever Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Typhoid Fever Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Typhoid Fever Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Typhoid Fever Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
PaxVax
Biomed
Prokarium
China National Biotec Group
By Type
Live Attenuated Vaccine
Conjugate Vaccine
Capsular Polysaccharide Vaccines
Others
By Application
Government Institution
Private Sector
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Typhoid Fever Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Typhoid Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Typhoid Fever Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Typhoid Fever Vaccines Definition
1.2 Market by Type
1.2.1 Global Typhoid Fever Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Live Attenuated Vaccine
1.2.3 Conjugate Vaccine
1.2.4 Capsular Polysaccharide Vaccines
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Typhoid Fever Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Government Institution
1.3.3 Private Sector
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Typhoid Fever Vaccines Sales
2.1 Global Typhoid Fever Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Typhoid Fever Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Typhoid Fever Vaccines Revenue by Region
2.3.1 Global Typhoid Fever Vaccines Revenue by Region (2018-2024)
2.3.2 Global Typhoid Fever Vaccines Revenue by Region (2024-2034)
2.4 Global Typhoid Fever Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Typhoid Fever Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Typhoid Fever Vaccines Sales Quantity by Region
2.6.1 Global Typhoid Fever Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Typhoid Fever Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Typhoid Fever Vaccines Sales Quantity by Manufacturers
3.1.1 Global Typhoid Fever Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Typhoid Fever Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Typhoid Fever Vaccines Sales in 2022
3.2 Global Typhoid Fever Vaccines Revenue by Manufacturers
3.2.1 Global Typhoid Fever Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Typhoid Fever Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Typhoid Fever Vaccines Revenue in 2022
3.3 Global Typhoid Fever Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Typhoid Fever Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Typhoid Fever Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Typhoid Fever Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Typhoid Fever Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Typhoid Fever Vaccines Sales Quantity by Type
4.1.1 Global Typhoid Fever Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Typhoid Fever Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Typhoid Fever Vaccines Revenue by Type
4.2.1 Global Typhoid Fever Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Typhoid Fever Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Typhoid Fever Vaccines Price by Type
4.3.1 Global Typhoid Fever Vaccines Price by Type (2018-2024)
4.3.2 Global Typhoid Fever Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Typhoid Fever Vaccines Sales Quantity by Application
5.1.1 Global Typhoid Fever Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Typhoid Fever Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Typhoid Fever Vaccines Revenue by Application
5.2.1 Global Typhoid Fever Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Typhoid Fever Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Typhoid Fever Vaccines Price by Application
5.3.1 Global Typhoid Fever Vaccines Price by Application (2018-2024)
5.3.2 Global Typhoid Fever Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Typhoid Fever Vaccines Sales by Company
6.1.1 North America Typhoid Fever Vaccines Revenue by Company (2018-2024)
6.1.2 North America Typhoid Fever Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Typhoid Fever Vaccines Market Size by Type
6.2.1 North America Typhoid Fever Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Typhoid Fever Vaccines Revenue by Type (2018-2034)
6.3 North America Typhoid Fever Vaccines Market Size by Application
6.3.1 North America Typhoid Fever Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Typhoid Fever Vaccines Revenue by Application (2018-2034)
6.4 North America Typhoid Fever Vaccines Market Size by Country
6.4.1 North America Typhoid Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Typhoid Fever Vaccines Revenue by Country (2018-2034)
6.4.3 North America Typhoid Fever Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Typhoid Fever Vaccines Sales by Company
7.1.1 Europe Typhoid Fever Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Typhoid Fever Vaccines Revenue by Company (2018-2024)
7.2 Europe Typhoid Fever Vaccines Market Size by Type
7.2.1 Europe Typhoid Fever Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Typhoid Fever Vaccines Revenue by Type (2018-2034)
7.3 Europe Typhoid Fever Vaccines Market Size by Application
7.3.1 Europe Typhoid Fever Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Typhoid Fever Vaccines Revenue by Application (2018-2034)
7.4 Europe Typhoid Fever Vaccines Market Size by Country
7.4.1 Europe Typhoid Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Typhoid Fever Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Typhoid Fever Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Typhoid Fever Vaccines Sales by Company
8.1.1 China Typhoid Fever Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Typhoid Fever Vaccines Revenue by Company (2018-2024)
8.2 China Typhoid Fever Vaccines Market Size by Type
8.2.1 China Typhoid Fever Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Typhoid Fever Vaccines Revenue by Type (2018-2034)
8.3 China Typhoid Fever Vaccines Market Size by Application
8.3.1 China Typhoid Fever Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Typhoid Fever Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Typhoid Fever Vaccines Sales by Company
9.1.1 APAC Typhoid Fever Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Typhoid Fever Vaccines Revenue by Company (2018-2024)
9.2 APAC Typhoid Fever Vaccines Market Size by Type
9.2.1 APAC Typhoid Fever Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Typhoid Fever Vaccines Revenue by Type (2018-2034)
9.3 APAC Typhoid Fever Vaccines Market Size by Application
9.3.1 APAC Typhoid Fever Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Typhoid Fever Vaccines Revenue by Application (2018-2034)
9.4 APAC Typhoid Fever Vaccines Market Size by Region
9.4.1 APAC Typhoid Fever Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Typhoid Fever Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Typhoid Fever Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Typhoid Fever Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Typhoid Fever Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Typhoid Fever Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Typhoid Fever Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Sanofi Pasteur Typhoid Fever Vaccines Products and Services
11.1.5 Sanofi Pasteur Typhoid Fever Vaccines SWOT Analysis
11.1.6 Sanofi Pasteur Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GlaxoSmithKline Typhoid Fever Vaccines Products and Services
11.2.5 GlaxoSmithKline Typhoid Fever Vaccines SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Bharat Biotech
11.3.1 Bharat Biotech Company Information
11.3.2 Bharat Biotech Overview
11.3.3 Bharat Biotech Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Bharat Biotech Typhoid Fever Vaccines Products and Services
11.3.5 Bharat Biotech Typhoid Fever Vaccines SWOT Analysis
11.3.6 Bharat Biotech Recent Developments
11.4 PaxVax
11.4.1 PaxVax Company Information
11.4.2 PaxVax Overview
11.4.3 PaxVax Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 PaxVax Typhoid Fever Vaccines Products and Services
11.4.5 PaxVax Typhoid Fever Vaccines SWOT Analysis
11.4.6 PaxVax Recent Developments
11.5 Biomed
11.5.1 Biomed Company Information
11.5.2 Biomed Overview
11.5.3 Biomed Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Biomed Typhoid Fever Vaccines Products and Services
11.5.5 Biomed Typhoid Fever Vaccines SWOT Analysis
11.5.6 Biomed Recent Developments
11.6 Prokarium
11.6.1 Prokarium Company Information
11.6.2 Prokarium Overview
11.6.3 Prokarium Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Prokarium Typhoid Fever Vaccines Products and Services
11.6.5 Prokarium Typhoid Fever Vaccines SWOT Analysis
11.6.6 Prokarium Recent Developments
11.7 China National Biotec Group
11.7.1 China National Biotec Group Company Information
11.7.2 China National Biotec Group Overview
11.7.3 China National Biotec Group Typhoid Fever Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 China National Biotec Group Typhoid Fever Vaccines Products and Services
11.7.5 China National Biotec Group Typhoid Fever Vaccines SWOT Analysis
11.7.6 China National Biotec Group Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Typhoid Fever Vaccines Value Chain Analysis
12.2 Typhoid Fever Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Typhoid Fever Vaccines Production Mode & Process
12.4 Typhoid Fever Vaccines Sales and Marketing
12.4.1 Typhoid Fever Vaccines Sales Channels
12.4.2 Typhoid Fever Vaccines Distributors
12.5 Typhoid Fever Vaccines Customers
13 Market Dynamics
13.1 Typhoid Fever Vaccines Industry Trends
13.2 Typhoid Fever Vaccines Market Drivers
13.3 Typhoid Fever Vaccines Market Challenges
13.4 Typhoid Fever Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Live Attenuated Vaccine
Table 3. Major Manufacturers of Conjugate Vaccine
Table 4. Major Manufacturers of Capsular Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Typhoid Fever Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Typhoid Fever Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Typhoid Fever Vaccines Revenue Market Share by Region (2018-2024)
Table 10. Global Typhoid Fever Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Typhoid Fever Vaccines Revenue Market Share by Region (2024-2034)
Table 12. Global Typhoid Fever Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Doses)
Table 13. Global Typhoid Fever Vaccines Sales by Region (2018-2024) & (K Doses)
Table 14. Global Typhoid Fever Vaccines Sales Market Share by Region (2018-2024)
Table 15. Global Typhoid Fever Vaccines Sales by Region (2024-2034) & (K Doses)
Table 16. Global Typhoid Fever Vaccines Sales Market Share by Region (2024-2034)
Table 17. Global Typhoid Fever Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Doses)
Table 18. Global Typhoid Fever Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Typhoid Fever Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Typhoid Fever Vaccines Revenue Share by Manufacturers (2018-2024)
Table 21. Global Typhoid Fever Vaccines Price by Manufacturers 2018-2024 (USD/Dose)
Table 22. Global Key Players of Typhoid Fever Vaccines, Industry Ranking, 2021 VS 2022
Table 23. Global Typhoid Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Typhoid Fever Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Typhoid Fever Vaccines as of 2022)
Table 25. Global Key Manufacturers of Typhoid Fever Vaccines, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Typhoid Fever Vaccines, Product Offered and Application
Table 27. Global Key Manufacturers of Typhoid Fever Vaccines, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Typhoid Fever Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 30. Global Typhoid Fever Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 31. Global Typhoid Fever Vaccines Sales Quantity Share by Type (2018-2024)
Table 32. Global Typhoid Fever Vaccines Sales Quantity Share by Type (2024-2034)
Table 33. Global Typhoid Fever Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Typhoid Fever Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Typhoid Fever Vaccines Revenue Share by Type (2018-2024)
Table 36. Global Typhoid Fever Vaccines Revenue Share by Type (2024-2034)
Table 37. Typhoid Fever Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 38. Global Typhoid Fever Vaccines Price Forecast by Type (2024-2034) & (USD/Dose)
Table 39. Global Typhoid Fever Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 40. Global Typhoid Fever Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 41. Global Typhoid Fever Vaccines Sales Quantity Share by Application (2018-2024)
Table 42. Global Typhoid Fever Vaccines Sales Quantity Share by Application (2024-2034)
Table 43. Global Typhoid Fever Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Typhoid Fever Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Typhoid Fever Vaccines Revenue Share by Application (2018-2024)
Table 46. Global Typhoid Fever Vaccines Revenue Share by Application (2024-2034)
Table 47. Typhoid Fever Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 48. Global Typhoid Fever Vaccines Price Forecast by Application (2024-2034) & (USD/Dose)
Table 49. North America Typhoid Fever Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Typhoid Fever Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 51. North America Typhoid Fever Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 52. North America Typhoid Fever Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 53. North America Typhoid Fever Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Typhoid Fever Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Typhoid Fever Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 56. North America Typhoid Fever Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 57. North America Typhoid Fever Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Typhoid Fever Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Typhoid Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Typhoid Fever Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Typhoid Fever Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Typhoid Fever Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 63. North America Typhoid Fever Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 64. Europe Typhoid Fever Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 65. Europe Typhoid Fever Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Typhoid Fever Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 67. Europe Typhoid Fever Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 68. Europe Typhoid Fever Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Typhoid Fever Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Typhoid Fever Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 71. Europe Typhoid Fever Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 72. Europe Typhoid Fever Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Typhoid Fever Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Typhoid Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Typhoid Fever Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Typhoid Fever Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Typhoid Fever Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 78. Europe Typhoid Fever Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 79. China Typhoid Fever Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 80. China Typhoid Fever Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Typhoid Fever Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 82. China Typhoid Fever Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 83. China Typhoid Fever Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Typhoid Fever Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Typhoid Fever Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 86. China Typhoid Fever Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 87. China Typhoid Fever Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Typhoid Fever Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Typhoid Fever Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 90. APAC Typhoid Fever Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Typhoid Fever Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 92. APAC Typhoid Fever Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 93. APAC Typhoid Fever Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Typhoid Fever Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Typhoid Fever Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 96. APAC Typhoid Fever Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 97. APAC Typhoid Fever Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Typhoid Fever Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Typhoid Fever Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Typhoid Fever Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Typhoid Fever Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Typhoid Fever Vaccines Sales Quantity by Region (2018-2024) & (K Doses)
Table 103. APAC Typhoid Fever Vaccines Sales Quantity by Region (2024-2034) & (K Doses)
Table 104. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 105. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 107. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 108. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 111. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 112. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 118. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 119. Sanofi Pasteur Company Information
Table 120. Sanofi Pasteur Description and Overview
Table 121. Sanofi Pasteur Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 122. Sanofi Pasteur Typhoid Fever Vaccines Product and Services
Table 123. Sanofi Pasteur Typhoid Fever Vaccines SWOT Analysis
Table 124. Sanofi Pasteur Recent Developments
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Description and Overview
Table 127. GlaxoSmithKline Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 128. GlaxoSmithKline Typhoid Fever Vaccines Product and Services
Table 129. GlaxoSmithKline Typhoid Fever Vaccines SWOT Analysis
Table 130. GlaxoSmithKline Recent Developments
Table 131. Bharat Biotech Company Information
Table 132. Bharat Biotech Description and Overview
Table 133. Bharat Biotech Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 134. Bharat Biotech Typhoid Fever Vaccines Product and Services
Table 135. Bharat Biotech Typhoid Fever Vaccines SWOT Analysis
Table 136. Bharat Biotech Recent Developments
Table 137. PaxVax Company Information
Table 138. PaxVax Description and Overview
Table 139. PaxVax Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 140. PaxVax Typhoid Fever Vaccines Product and Services
Table 141. PaxVax Typhoid Fever Vaccines SWOT Analysis
Table 142. PaxVax Recent Developments
Table 143. Biomed Company Information
Table 144. Biomed Description and Overview
Table 145. Biomed Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 146. Biomed Typhoid Fever Vaccines Product and Services
Table 147. Biomed Typhoid Fever Vaccines SWOT Analysis
Table 148. Biomed Recent Developments
Table 149. Prokarium Company Information
Table 150. Prokarium Description and Overview
Table 151. Prokarium Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 152. Prokarium Typhoid Fever Vaccines Product and Services
Table 153. Prokarium Typhoid Fever Vaccines SWOT Analysis
Table 154. Prokarium Recent Developments
Table 155. China National Biotec Group Company Information
Table 156. China National Biotec Group Description and Overview
Table 157. China National Biotec Group Typhoid Fever Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 158. China National Biotec Group Typhoid Fever Vaccines Product and Services
Table 159. China National Biotec Group Typhoid Fever Vaccines SWOT Analysis
Table 160. China National Biotec Group Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Typhoid Fever Vaccines Distributors List
Table 164. Typhoid Fever Vaccines Customers List
Table 165. Typhoid Fever Vaccines Market Trends
Table 166. Typhoid Fever Vaccines Market Drivers
Table 167. Typhoid Fever Vaccines Market Challenges
Table 168. Typhoid Fever Vaccines Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Fever Vaccines Product Picture
Figure 2. Global Typhoid Fever Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Typhoid Fever Vaccines Market Share by Type in 2022 & 2034
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Conjugate Vaccine Product Picture
Figure 6. Capsular Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Typhoid Fever Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Typhoid Fever Vaccines Market Share by Application in 2022 & 2034
Figure 10. Government Institution
Figure 11. Private Sector
Figure 12. Typhoid Fever Vaccines Report Years Considered
Figure 13. Global Typhoid Fever Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Typhoid Fever Vaccines Revenue 2018-2034 (US$ Million)
Figure 15. Global Typhoid Fever Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Typhoid Fever Vaccines Sales Quantity 2018-2034 (K Doses)
Figure 17. Global Typhoid Fever Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Typhoid Fever Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Typhoid Fever Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 20. North America Typhoid Fever Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Typhoid Fever Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 22. Europe Typhoid Fever Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Typhoid Fever Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 24. China Typhoid Fever Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Typhoid Fever Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 26. APAC Typhoid Fever Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 28. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Typhoid Fever Vaccines Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Typhoid Fever Vaccines Revenue in 2022
Figure 31. Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
Figure 34. Global Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
Figure 36. North America Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 37. North America Typhoid Fever Vaccines Sales Quantity Market Share by Company in 2022
Figure 38. North America Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. North America Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America Typhoid Fever Vaccines Revenue Share by Country (2018-2034)
Figure 43. North America Typhoid Fever Vaccines Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Typhoid Fever Vaccines Sales Quantity Market Share by Company in 2022
Figure 47. Europe Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 48. Europe Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
Figure 50. Europe Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
Figure 52. Europe Typhoid Fever Vaccines Revenue Share by Country (2018-2034)
Figure 53. Europe Typhoid Fever Vaccines Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. France Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. China Typhoid Fever Vaccines Sales Quantity Market Share by Company in 2022
Figure 60. China Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 61. China Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
Figure 63. China Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
Figure 65. APAC Typhoid Fever Vaccines Sales Quantity Market Share by Company in 2022
Figure 66. APAC Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 67. APAC Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. APAC Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC Typhoid Fever Vaccines Revenue Share by Region (2018-2034)
Figure 72. APAC Typhoid Fever Vaccines Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. India Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Typhoid Fever Vaccines Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Typhoid Fever Vaccines Revenue Share by Country (2018-2034)
Figure 86. Brazil Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Typhoid Fever Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Typhoid Fever Vaccines Value Chain
Figure 92. Typhoid Fever Vaccines Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries